What they were paid
Alto Neuroscience Director Compensation Table · the one fiscal year held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $17,906 | — | $0 | — | $17,906 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Alto Neuroscience, Inc. DEF 14A filed March 26, 2026, accession 0001104659-26-035180, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025Alto Neuroscience pays directors a $40,000 cash retainer.
Committees
FY2025 · as the proxy prints themNominating/Governance (Chair)
The rest of the Alto Neuroscience board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Amit Etkin, M.D., Ph.D | Director | $0 |
| Andrew Dreyfus | Independent Director | $80,263 |
| Christopher Nixon Cox | Lead Independent Director | $110,543 |
| Gwill York | Independent Director | $88,178 |
| Husseini Manji, M.D | Independent Director | $73,129 |
| Raymond Sanchez, M.D | Independent Director | $84,904 |
The full Alto Neuroscience compensation record
free company briefThis page is one director within Alto Neuroscience's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat